Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® ...
Art therapy in China emerged during the 1990s and is still in its early stage of cultural adaptation and methodological refinement. This study explores the development and application of art therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback